Physician profile
Kunal Sarkar
NPI 1407800162
$1,848.50
in general payments reported to CMS, 2019-2025
22 companies · $171 in 2025
The $171 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $343 · 2020: $147 · 2021: $313 · 2022: $461 · 2023: $242 · 2024: $172 · 2025: $171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $585.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $584.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $434.35 | 2020-2025 | Auryon Laser System 100-120 Vac |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $308.88 | 2019-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $164.18 | 2021-2024 | Verquvo |
| Cook Medical LLC | $163.98 | 2022 | |
| Boston Scientific Corporation | $162.55 | 2019-2022 | |
| Amgen INC. | $102.79 | 2020-2025 | Repatha, Repatha |
| Penumbra, INC. | $72.11 | 2025 | Indigo System |
| Novartis Pharmaceuticals Corporation | $67.44 | 2023-2025 | |
| Janssen Pharmaceuticals, INC | $67.17 | 2020-2024 | Xarelto |
| Esperion Therapeutics, INC. | $44.59 | 2022 | |
| Pfizer INC. | $39.52 | 2022-2024 | |
| Cardiva Medical, INC. | $31.45 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Medtronic, INC. | $25.07 | 2025 | Corevalve Evolut R |
| Kowa Pharmaceuticals America, INC. | $24.66 | 2020-2021 | |
| Abiomed | $22.98 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lexicon Pharmaceuticals, INC. | $21.25 | 2023 | Inpefa |
| Catheter Precision, INC. Fka Ra Medical Systems, INC. | $20.35 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.47 | 2023 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $17.38 | 2021 | |
| Convatec INC. | $13.18 | 2023 | |
| Medicomp INC | $13.09 | 2023 | Telepatch Cardiac Monitor |
| Abbott Laboratories | $13.06 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kunal Sarkar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.